Carrageenan Is a Potent Inhibitor of Papillomavirus Infection

Christopher B Buck; Cynthia D Thompson; Jeffrey N Roberts; Martin Müller; Douglas R Lowy; John T Schiller

doi:10.1371/journal.ppat.0020069

Loading metrics

Open Access

Peer-reviewed

Research Article

Carrageenan Is a Potent Inhibitor of Papillomavirus Infection

Christopher B Buck,

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America
⨯
Cynthia D Thompson,

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America
⨯
Jeffrey N Roberts,

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America
⨯
Martin Müller,

Affiliation Forschungsschwerpunkt für Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany
⨯
Douglas R Lowy,

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America
⨯
John T Schiller

*To whom correspondence should be addressed. E-mail: schillej@dc37a.nci.nih.gov

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America
⨯

Carrageenan Is a Potent Inhibitor of Papillomavirus Infection

Christopher B Buck,
Cynthia D Thompson,
Jeffrey N Roberts,
Martin Müller,
Douglas R Lowy,
John T Schiller

Published: July 14, 2006
https://doi.org/10.1371/journal.ppat.0020069

About the Authors

Christopher B Buck

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

Cynthia D Thompson

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

Jeffrey N Roberts

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

Martin Müller

Affiliation Forschungsschwerpunkt für Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany

Douglas R Lowy

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

John T Schiller

*To whom correspondence should be addressed. E-mail: schillej@dc37a.nci.nih.gov

Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

CBB, DRL, and JTS conceived and designed the experiments. CBB and CDT performed the experiments. CBB, CDT, DRL, and JTS analyzed the data. JNR and MM contributed reagents/materials/analysis tools. CBB, DRL, and JTS wrote the paper.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Human papillomavirus infection
Is the Subject Area "Human papillomavirus infection" applicable to this article?

Thanks for your feedback.
Viral packaging
Is the Subject Area "Viral packaging" applicable to this article?

Thanks for your feedback.
HPV-16
Is the Subject Area "HPV-16" applicable to this article?

Thanks for your feedback.
Polysaccharides
Is the Subject Area "Polysaccharides" applicable to this article?

Thanks for your feedback.
Lubrication
Is the Subject Area "Lubrication" applicable to this article?

Thanks for your feedback.
Sexually transmitted diseases
Is the Subject Area "Sexually transmitted diseases" applicable to this article?

Thanks for your feedback.
Sulfates
Is the Subject Area "Sulfates" applicable to this article?

Thanks for your feedback.
Papillomaviruses
Is the Subject Area "Papillomaviruses" applicable to this article?

Thanks for your feedback.